Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_double_gel_48h.class.cls #double_gel_8d_versus_double_gel_48h_repos |
Phenotype | class.cls#double_gel_8d_versus_double_gel_48h_repos |
Upregulated in class | double_gel_8d |
GeneSet | CELL_CELL_ADHESION |
Enrichment Score (ES) | 0.57444423 |
Normalized Enrichment Score (NES) | 1.8614634 |
Nominal p-value | 0.0 |
FDR q-value | 0.018082067 |
FWER p-Value | 0.802 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | CLDN7 | CLDN7 Entrez,  Source | claudin 7 | 24 | 0.780 | 0.1309 | Yes |
2 | MGP | MGP Entrez,  Source | matrix Gla protein | 52 | 0.634 | 0.2368 | Yes |
3 | PVRL2 | PVRL2 Entrez,  Source | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 127 | 0.468 | 0.3109 | Yes |
4 | CLDN1 | CLDN1 Entrez,  Source | claudin 1 | 158 | 0.436 | 0.3829 | Yes |
5 | CDH13 | CDH13 Entrez,  Source | cadherin 13, H-cadherin (heart) | 223 | 0.366 | 0.4404 | Yes |
6 | APOA4 | APOA4 Entrez,  Source | apolipoprotein A-IV | 253 | 0.340 | 0.4961 | Yes |
7 | CLDN4 | CLDN4 Entrez,  Source | claudin 4 | 570 | 0.212 | 0.5084 | Yes |
8 | CLDN3 | CLDN3 Entrez,  Source | claudin 3 | 788 | 0.172 | 0.5213 | Yes |
9 | LMO4 | LMO4 Entrez,  Source | LIM domain only 4 | 808 | 0.169 | 0.5486 | Yes |
10 | CX3CL1 | CX3CL1 Entrez,  Source | chemokine (C-X3-C motif) ligand 1 | 837 | 0.164 | 0.5744 | Yes |
11 | ACVRL1 | ACVRL1 Entrez,  Source | activin A receptor type II-like 1 | 1574 | 0.104 | 0.5368 | No |
12 | COL11A1 | COL11A1 Entrez,  Source | collagen, type XI, alpha 1 | 1749 | 0.095 | 0.5399 | No |
13 | NLGN1 | NLGN1 Entrez,  Source | neuroligin 1 | 2365 | 0.072 | 0.5059 | No |
14 | CDK5R1 | CDK5R1 Entrez,  Source | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 2373 | 0.072 | 0.5176 | No |
15 | NPTN | NPTN Entrez,  Source | neuroplastin | 3153 | 0.051 | 0.4676 | No |
16 | CDKN2A | CDKN2A Entrez,  Source | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 3401 | 0.045 | 0.4567 | No |
17 | SYK | SYK Entrez,  Source | spleen tyrosine kinase | 3649 | 0.040 | 0.4449 | No |
18 | CD47 | CD47 Entrez,  Source | CD47 molecule | 3700 | 0.039 | 0.4477 | No |
19 | CLDN19 | CLDN19 Entrez,  Source | claudin 19 | 3919 | 0.034 | 0.4371 | No |
20 | BMP1 | BMP1 Entrez,  Source | bone morphogenetic protein 1 | 4389 | 0.026 | 0.4062 | No |
21 | BCL10 | BCL10 Entrez,  Source | B-cell CLL/lymphoma 10 | 4947 | 0.016 | 0.3670 | No |
22 | CNTN4 | CNTN4 Entrez,  Source | contactin 4 | 5393 | 0.009 | 0.3350 | No |
23 | CLDN8 | CLDN8 Entrez,  Source | claudin 8 | 5544 | 0.007 | 0.3249 | No |
24 | ATP2C1 | ATP2C1 Entrez,  Source | ATPase, Ca++ transporting, type 2C, member 1 | 5638 | 0.005 | 0.3188 | No |
25 | DLG1 | DLG1 Entrez,  Source | discs, large homolog 1 (Drosophila) | 5729 | 0.004 | 0.3127 | No |
26 | TNF | TNF Entrez,  Source | tumor necrosis factor (TNF superfamily, member 2) | 5914 | 0.001 | 0.2990 | No |
27 | CD164 | CD164 Entrez,  Source | CD164 molecule, sialomucin | 6173 | -0.003 | 0.2801 | No |
28 | AMIGO3 | AMIGO3 Entrez,  Source | adhesion molecule with Ig-like domain 3 | 6177 | -0.003 | 0.2803 | No |
29 | CALCA | CALCA Entrez,  Source | calcitonin/calcitonin-related polypeptide, alpha | 6370 | -0.006 | 0.2669 | No |
30 | NINJ2 | NINJ2 Entrez,  Source | ninjurin 2 | 6616 | -0.009 | 0.2500 | No |
31 | ITGB1 | ITGB1 Entrez,  Source | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 6774 | -0.012 | 0.2402 | No |
32 | LGALS7 | LGALS7 Entrez,  Source | lectin, galactoside-binding, soluble, 7 (galectin 7) | 6899 | -0.014 | 0.2332 | No |
33 | PKD1 | PKD1 Entrez,  Source | polycystic kidney disease 1 (autosomal dominant) | 7190 | -0.018 | 0.2144 | No |
34 | ROBO2 | ROBO2 Entrez,  Source | roundabout, axon guidance receptor, homolog 2 (Drosophila) | 7401 | -0.021 | 0.2022 | No |
35 | EMCN | EMCN Entrez,  Source | endomucin | 7455 | -0.022 | 0.2019 | No |
36 | CLDN11 | CLDN11 Entrez,  Source | claudin 11 (oligodendrocyte transmembrane protein) | 8011 | -0.031 | 0.1655 | No |
37 | PVRL1 | PVRL1 Entrez,  Source | poliovirus receptor-related 1 (herpesvirus entry mediator C; nectin) | 8795 | -0.044 | 0.1140 | No |
38 | NCAM2 | NCAM2 Entrez,  Source | neural cell adhesion molecule 2 | 9021 | -0.048 | 0.1052 | No |
39 | NF2 | NF2 Entrez,  Source | neurofibromin 2 (bilateral acoustic neuroma) | 9310 | -0.053 | 0.0925 | No |
40 | CD93 | CD93 Entrez,  Source | CD93 molecule | 9341 | -0.053 | 0.0993 | No |
41 | AMIGO2 | AMIGO2 Entrez,  Source | adhesion molecule with Ig-like domain 2 | 9354 | -0.053 | 0.1075 | No |
42 | CLDN14 | CLDN14 Entrez,  Source | claudin 14 | 9533 | -0.056 | 0.1037 | No |
43 | CLDN5 | CLDN5 Entrez,  Source | claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) | 9647 | -0.059 | 0.1052 | No |
44 | GTPBP4 | GTPBP4 Entrez,  Source | GTP binding protein 4 | 10400 | -0.075 | 0.0613 | No |
45 | ITGB2 | ITGB2 Entrez,  Source | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 10432 | -0.076 | 0.0718 | No |
46 | CLDN16 | CLDN16 Entrez,  Source | claudin 16 | 10660 | -0.081 | 0.0686 | No |
47 | REG3A | REG3A Entrez,  Source | regenerating islet-derived 3 alpha | 11065 | -0.092 | 0.0539 | No |
48 | THY1 | THY1 Entrez,  Source | Thy-1 cell surface antigen | 11400 | -0.102 | 0.0461 | No |
49 | PTEN | PTEN Entrez,  Source | phosphatase and tensin homolog (mutated in multiple advanced cancers 1) | 11578 | -0.108 | 0.0513 | No |
50 | ROBO1 | ROBO1 Entrez,  Source | roundabout, axon guidance receptor, homolog 1 (Drosophila) | 12116 | -0.133 | 0.0335 | No |
51 | RASA1 | RASA1 Entrez,  Source | RAS p21 protein activator (GTPase activating protein) 1 | 12457 | -0.152 | 0.0337 | No |
52 | EGFR | EGFR Entrez,  Source | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 12857 | -0.193 | 0.0365 | No |